Medications

NIH to launch human safety study of Ebola vaccine candidate

Initial human testing of an investigational vaccine to prevent Ebola virus disease will begin next week by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Diseases, Conditions, Syndromes

Experimental chikungunya vaccine induces robust antibody response

An experimental vaccine to prevent the mosquito-borne viral illness chikungunya elicited neutralizing antibodies in all 25 adult volunteers who participated in a recent early-stage clinical trial conducted by researchers ...

Medications

Scientists racing to test Ebola vaccines in humans

Scientists are racing to begin the first human safety tests of two experimental Ebola vaccines, but it won't be easy to prove that the shots and other potential treatments in the pipeline really work.

Diseases, Conditions, Syndromes

Ebola outbreak speeds up efforts to find a vaccine

There is no vaccine on the world market to protect against the deadly Ebola virus, but experts say the fast-growing outbreak in West Africa is speeding efforts to test one.

Diseases, Conditions, Syndromes

Vaccine candidate against Chikungunya fever proves successful

A prophylactic vaccine candidate against Chikungunya fever, developed by the Austrian biotech company Themis Bioscience GmbH induces a significant neutralizing immune response and was also confirmed as safe. These are the ...

page 35 from 40